FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3215208029> ?p ?o ?g. }

• W3215208029 endingPage "1260" @default.
• W3215208029 startingPage "1248" @default.
• W3215208029 abstract "To evaluate COVID-19 vaccine breakthrough infections among immunocompromised (IC) individuals.Individuals vaccinated with BNT162b2 were selected from the US HealthVerity database (10 December 2020 to 8 July 2021). COVID-19 vaccine breakthrough infections were examined in fully vaccinated (≥14 days after 2nd dose) IC individuals (IC cohort), 12 mutually exclusive IC condition groups, and a non-IC cohort. IC conditions were identified using an algorithm based on diagnosis codes and immunosuppressive (IS) medication usage.Of 1,277,747 individuals ≥16 years of age who received 2 BNT162b2 doses, 225,796 (17.7%) were identified as IC (median age: 58 years; 56.3% female). The most prevalent IC conditions were solid malignancy (32.0%), kidney disease (19.5%), and rheumatologic/inflammatory conditions (16.7%). Among the fully vaccinated IC and non-IC cohorts, a total of 978 breakthrough infections were observed during the study period; 124 (12.7%) resulted in hospitalization and 2 (0.2%) were inpatient deaths. IC individuals accounted for 38.2% (N = 374) of all breakthrough infections, 59.7% (N = 74) of all hospitalizations, and 100% (N = 2) of inpatient deaths. The proportion with breakthrough infections was 3 times higher in the IC cohort compared to the non-IC cohort (N = 374 [0.18%] vs. N = 604 [0.06%]; unadjusted incidence rates were 0.89 and 0.34 per 100 person-years, respectively. Organ transplant recipients had the highest incidence rate; those with >1 IC condition, antimetabolite usage, primary immunodeficiencies, and hematologic malignancies also had higher incidence rates compared to the overall IC cohort. Incidence rates in older (≥65 years old) IC individuals were generally higher versus younger IC individuals (<65).This retrospective analysis relied on coding accuracy and had limited capture of COVID-19 vaccine receipt.COVID-19 vaccine breakthrough infections are rare but are more common and severe in IC individuals. The findings from this large study support the FDA authorization and CDC recommendations to offer a 3rd vaccine dose to increase protection among IC individuals." @default.
• W3215208029 created "2021-12-06" @default.
• W3215208029 creator A5034367911 @default.
• W3215208029 creator A5040702988 @default.
• W3215208029 creator A5043881768 @default.
• W3215208029 creator A5045452931 @default.
• W3215208029 creator A5063684760 @default.
• W3215208029 creator A5076165148 @default.
• W3215208029 creator A5077433815 @default.
• W3215208029 creator A5078138014 @default.
• W3215208029 creator A5083052414 @default.
• W3215208029 creator A5089172085 @default.
• W3215208029 creator A5089964898 @default.
• W3215208029 date "2021-01-01" @default.
• W3215208029 modified "2023-10-02" @default.
• W3215208029 title "Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2" @default.
• W3215208029 cites W2193885256 @default.
• W3215208029 cites W3017761402 @default.
• W3215208029 cites W3111255098 @default.
• W3215208029 cites W3121038283 @default.
• W3215208029 cites W3121268532 @default.
• W3215208029 cites W3131688063 @default.
• W3215208029 cites W3136355231 @default.
• W3215208029 cites W3137328974 @default.
• W3215208029 cites W3137814380 @default.
• W3215208029 cites W3159638076 @default.
• W3215208029 cites W3162622073 @default.
• W3215208029 cites W3164041179 @default.
• W3215208029 cites W3174588189 @default.
• W3215208029 cites W3187511802 @default.
• W3215208029 cites W3187850115 @default.
• W3215208029 cites W3196324863 @default.
• W3215208029 cites W3197781843 @default.
• W3215208029 cites W3201177512 @default.
• W3215208029 cites W3204638695 @default.
• W3215208029 cites W4205483821 @default.
• W3215208029 cites W4225505755 @default.
• W3215208029 doi "https://doi.org/10.1080/13696998.2021.2002063" @default.
• W3215208029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34844493" @default.
• W3215208029 hasPublicationYear "2021" @default.
• W3215208029 type Work @default.
• W3215208029 sameAs 3215208029 @default.
• W3215208029 citedByCount "36" @default.
• W3215208029 countsByYear W32152080292021 @default.
• W3215208029 countsByYear W32152080292022 @default.
• W3215208029 countsByYear W32152080292023 @default.
• W3215208029 crossrefType "journal-article" @default.
• W3215208029 hasAuthorship W3215208029A5034367911 @default.
• W3215208029 hasAuthorship W3215208029A5040702988 @default.
• W3215208029 hasAuthorship W3215208029A5043881768 @default.
• W3215208029 hasAuthorship W3215208029A5045452931 @default.
• W3215208029 hasAuthorship W3215208029A5063684760 @default.
• W3215208029 hasAuthorship W3215208029A5076165148 @default.
• W3215208029 hasAuthorship W3215208029A5077433815 @default.
• W3215208029 hasAuthorship W3215208029A5078138014 @default.
• W3215208029 hasAuthorship W3215208029A5083052414 @default.
• W3215208029 hasAuthorship W3215208029A5089172085 @default.
• W3215208029 hasAuthorship W3215208029A5089964898 @default.
• W3215208029 hasBestOaLocation W32152080291 @default.
• W3215208029 hasConcept C120665830 @default.
• W3215208029 hasConcept C121332964 @default.
• W3215208029 hasConcept C126322002 @default.
• W3215208029 hasConcept C187212893 @default.
• W3215208029 hasConcept C61511704 @default.
• W3215208029 hasConcept C71924100 @default.
• W3215208029 hasConcept C72563966 @default.
• W3215208029 hasConceptScore W3215208029C120665830 @default.
• W3215208029 hasConceptScore W3215208029C121332964 @default.
• W3215208029 hasConceptScore W3215208029C126322002 @default.
• W3215208029 hasConceptScore W3215208029C187212893 @default.
• W3215208029 hasConceptScore W3215208029C61511704 @default.
• W3215208029 hasConceptScore W3215208029C71924100 @default.
• W3215208029 hasConceptScore W3215208029C72563966 @default.
• W3215208029 hasIssue "1" @default.
• W3215208029 hasLocation W32152080291 @default.
• W3215208029 hasLocation W32152080292 @default.
• W3215208029 hasLocation W32152080293 @default.
• W3215208029 hasLocation W32152080294 @default.
• W3215208029 hasOpenAccess W3215208029 @default.
• W3215208029 hasPrimaryLocation W32152080291 @default.
• W3215208029 hasRelatedWork W1580426574 @default.
• W3215208029 hasRelatedWork W1984877488 @default.
• W3215208029 hasRelatedWork W2089620537 @default.
• W3215208029 hasRelatedWork W2275480158 @default.
• W3215208029 hasRelatedWork W2323950372 @default.
• W3215208029 hasRelatedWork W2371214482 @default.
• W3215208029 hasRelatedWork W2603773853 @default.
• W3215208029 hasRelatedWork W2929987155 @default.
• W3215208029 hasRelatedWork W3095306390 @default.
• W3215208029 hasRelatedWork W4238089809 @default.
• W3215208029 hasVolume "24" @default.
• W3215208029 isParatext "false" @default.
• W3215208029 isRetracted "false" @default.
• W3215208029 magId "3215208029" @default.
• W3215208029 workType "article" @default.